On the other hand, the anti-apoptotic markers Bcl-2 and Bcl-XL are elevated in BPH but significantly reduced by HCQ or FIN, with the combination showing a stronger effect (Fig. 3C and D). Here, BCL2L1 is linked to benign prostatic hyperplasia.